Arindam Bhattacharyya

Dr. Arindam Bhattacharyya


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2008 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
SCSoumya Chatterjee
Soumya Chatterjee
SKSubhadip Kundu
Subhadip Kundu
ABArindam Bhattacharyya
Arindam Bhattacharyya
CHChristian Hartinger
Christian Hartinger
PDPaul Dyson
Paul Dyson

15 December 2019 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SBSubir Biswas
Subir Biswas
GMGunjan Mandal
Gunjan Mandal
SCSougata Roy Chowdhury
Sougata Roy Chowdhury
SPSuman Purohit
Suman Purohit
KPKyle K. Payne
Kyle K. Payne
ABArindam Bhattacharyya
Arindam Bhattacharyya
Tumor-associated macrophages are major contributors to malignant progression and resistance to immunotherapy, but the mechanisms governing their differentiation from immature myeloid precursors remain incompletely understood. In this study, we demonstrate that exosomes secreted by human and mouse tumor-educated mesenchymal stem cells (MSCs) drive accelerated breast cancer progression by inducing differentiation of monocytic myeloid-derived suppressor cells into highly immunosuppressive M2-polarized macrophages at tumor beds. Mechanistically, MSC-derived exosomes but not exosomes from tumor cells contain TGF-β, C1q, and semaphorins, which promote myeloid tolerogenic activity by driving PD-L1 overexpression in both immature myelomonocytic precursors and committed CD206+ macrophages and by inducing differentiation of MHC class II+ macrophages with enhanced l-Arginase activity and IL-10 secretion at tumor beds. Accordingly, administration of tumor-associated murine MSC-derived exosomes accelerates tumor growth by dampening antitumor immunity, and macrophage depletion eliminates exosome-dependent differences in malignant progression. Our results unveil a new role for MSC-derived exosomes in the differentiation of myeloid-derived suppressor cells into macrophages, which governs malignant growth. Key Points Breast tumor MSC-derived exosomes elicit differentiation of M-MDSC to TAM. MSC exosome–educated myeloid cells exacerbate immunosuppression in the breast TME. In vivo PD-L1 blockade neutralizes MSC exosome–driven breast cancer progression. Visual Abstract

13 December 2013 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
SBSubir Biswas
Subir Biswas
SSSuman Sengupta
Suman Sengupta
SCSougata Roy Chowdhury
Sougata Roy Chowdhury
SJSamir Jana
Samir Jana
GMGunjan Mandal
Gunjan Mandal
ABArindam Bhattacharyya
Arindam Bhattacharyya

24 August 2020 in Carcinogenesis
Verified
Journal Article
Closed access
PDF file
SCSoumya Chatterjee
Soumya Chatterjee
ACAnnesha Chatterjee
Annesha Chatterjee
SJSamir Jana
Samir Jana
SDSubhasis Dey
Subhasis Dey
HRHimansu Roy
Himansu Roy
ABArindam Bhattacharyya
Arindam Bhattacharyya
Tumor cells promote immune evasion through upregulation of programmed death-ligand 1 (PD-L1) that binds with programmed cell death protein 1 (PD1) on cytotoxic T cells and promote dysfunction. Though therapeutic efficacy of anti-PD1 antibody has remarkable effects on different type of cancers it is less effective in breast cancer (BC). Hence, more details understanding of PD-L1-mediated immune evasion is necessary. Here, we report BC cells secrete extracellular vesicles in form of exosomes carry PD-L1 and are highly immunosuppressive. Transforming growth factor beta (TGF-β) present in tumor microenvironment orchestrates BC cell secreted exosomal PD-L1 load. Circulating exosomal PD-L1 content is highly correlated with tumor TGF-β level. The later also found to be significantly associated with CD8+CD39+, CD8+PD1+ T-cell phenotype. Recombinant TGF-β1 dose dependently induces PD-L1 expression in Texos in vitro and blocking of TGF-β dimmed exosomal PD-L1 level. PD-L1 knocked down exosomes failed to suppress effector activity of activated CD8 T cells like tumor exosomes. While understanding its effect on T-cell receptor signaling, we found siPD-L1 exosomes failed to block phosphorylation of src family proteins, linker for activation of T cells and phosphoinositide phospholipase Cγ of CD8 T cells more than PD-L1 exosomes. In vivo inhibition of exosome release and TGF-β synergistically attenuates tumor burden by promoting Granzyme and interferon gamma release in tumor tissue depicting rejuvenation of exhausted T cells. Thus, we establish TGF-β as a promoter of exosomal PD-L1 and unveil a mechanism that tumor cells follow to promote CD8 T-cell dysfunction.

24 November 2011 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
SMSoham Mitra
Soham Mitra
NCNilkanta Chakrabarti
Nilkanta Chakrabarti
ABArindam Bhattacharyya
Arindam Bhattacharyya
Background: Paraquat (1, 1-dimethyl-4, 4-bipyridium dichloride; PQ) causes neurotoxicity, especially dopaminergic neurotoxicity, and is a supposed risk factor for Parkinson's disease (PD). However, the cellular and molecular mechanisms of PQ-induced neurodegeneration are far from clear. Previous studies have shown that PQ induces neuroinflammation and dopaminergic cell loss, but the prime cause of those events is still in debate.Methods: We examined the neuropathological effects of PQ not only in substantia nigra (SN) but also in frontal cortex (FC) and hippocampus of the progressive mouse (adult Swiss albino) model of PD-like neurodegeneration, using immunohistochemistry, western blots, and histological and biochemical analyses.Results: PQ caused differential patterns of changes in cellular morphology and expression of proteins related to PD and neuroinflammation in the three regions examined (SN, FC and hippocampus). Coincident with behavioral impairment and brain-specific ROS generation, there was differential immunolocalization and decreased expression levels of tyrosine hydroxylase (TH) in the three regions, whereas α-synuclein immunopositivity increased in hippocampus, increased in FC and decreased in SN. PQ-induced neuroinflammation was characterized by area-specific changes in localization and appearances of microglial cells with or without activation and increment in expression patterns of tumor necrosis factor-α in the three regions of mouse brain. Expression of interleukin-1β was increased in FC and hippocampus but not significantly changed in SN.Conclusion: The present study demonstrates that PQ induces ROS production and differential α-synuclein expression that promotes neuroinflammation in microglia-dependent or -independent manners, and produces different patterns of dopaminergic neurotoxicity in three different regions of mouse brain.

12 June 2009 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
SKSubhadip Kundu
Subhadip Kundu
SSSuman Sengupta
Suman Sengupta
SCSoumya Chatterjee
Soumya Chatterjee
SMSoham Mitra
Soham Mitra
ABArindam Bhattacharyya
Arindam Bhattacharyya
Background: Cadmium is one of the inflammation-related xenobiotics and has been regarded as a potent carcinogen. The relationship between inflammation and cell proliferation due to chronic infection has been studied, but the mechanism is not fully clear. Though the mode of cadmium toxicity is well characterized in animal cells, still it requires some further investigations. Previously we reported that cadmium induces immune cell death in Swiss albino mice. In the present study we showed that instead of inducing cell death mechanism, cadmium in low concentration triggers proliferation in mice lung cell and our results reveals that prior to the induction of proliferation it causes severe inflammation. Methods: Swiss albino mice were treated with different concentrations of cadmium to determine the LD50. Mice were subdivided (5 mice each) according to the exposure period (15, 30, 45, 60 days) and were given sub lethal dose (5 mg/Kg body weight) of cadmium chloride and ibuprofen (50 mg/Kg body weight, recommended dose) once in a week. SEM and histology were performed as evidence of changes in cellular morphology. Inflammation was measured by the expression of Cox-2 and MMPs. Expression of proinflammatory cytokines (Cox-2, IL-6), signaling and cell cycle regulatory molecules (STAT3, Akt, CyclinD1) were measured by western blot, ELISA and immunoprecipitation. Mutagenecity was evidenced by comet assay. Cell proliferation was determined by cell count, cell cycle and DNA analysis. Results: Prolonged exposure of low concentration of cadmium resulted in up regulation of proinflammatory cytokines and cell cycle regulatory molecules. Though NSAIDs like Ibuprofen reduces the expression of inflammatory cytokines, but it did not show any inhibitory effect on cadmium adopted lung cell proliferation. Conclusion: Our results prove that cadmium causes both inflammation and cell proliferation when applied in a low dose but proliferative changes occur independent of inflammation.